Find Drugs for Trauma (Emergency, Injury, Surgery) in Phase II Clinical Development

Lead Product(s): Nangibotide

Therapeutic Area: Trauma (Emergency, Injury, Surgery)

Highest Development Status: Phase II Product Type: Large molecule

Partner/Sponsor/Collaborator: Roche Diagnostics

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Licensing Agreement January 21, 2020

Details:

Inotrem entered a worldwide licensing agreement with Roche Diagnostics for the commercialization of a mechanism-based companion diagnostic test using a soluble plasma protein.

Lead Product(s): PB2452

Therapeutic Area: Trauma (Emergency, Injury, Surgery)

Highest Development Status: Phase II Product Type: Large molecule

Partner/Sponsor/Collaborator: SFJ Pharmaceuticals

Deal Size: $120.0 million Upfront Cash: Undisclosed

Deal Type: Collaboration January 10, 2020

Details:

The collaboration with SFJ provides PhaseBio with substantial funding to continue the rapid advancement of lead program, PB2452.